Xeris Biopharma Holdings, Inc.
XERSCIK 0001867096 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
33,582 bought / 151,666 sold
net −118,084 sh · −$1.24M
- buys
- 1
- sells
- 4
- insiders active
- 4
Filing tape
Filed Tue, Jul 7, 2026
- −45,000 sh · $383.2K
Pieper Steven — See Remarks
- Sold17,400Common Stock@ $8.50→ 1,393,653 held
- Sold27,600Common Stock@ $8.52→ 1,366,053 held
Filed Thu, Jul 2, 2026
- −90,000 sh · $722.5K
McCulloch Kevin — See Remarks
- Sold90,000Common Stock@ $8.03→ 1,691,126 held
- +33,582 sh
Kreher Nerissa — Director
- Granted33,582Common Stock→ 33,582 held
- Granted37,910Stock Option (Right to Buy)@ $8.00→ 37,910 held
- −16,666 sh · $133.9K
Hecht Beth — See Remarks
- Sold16,666Common Stock@ $8.03→ 1,161,128 held
Insiders on this tape
- Pieper StevenSee Remarks
- McCulloch KevinSee Remarks
- Kreher NerissaDirector
- Hecht BethSee Remarks
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.